Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

A combination drug known as BZA/CE may offer a safer alternative to tamoxifen in reducing breast cancer risk and improving ...

Women in midlife face a difficult trade-off. Many in their 40s to 60s face a high risk of breast cancer, especially during ...

Tamoxifen is a selective estrogen receptor modulator with estrogenic effects on cardiovascular risk factors, but its long-term impacts on cerebral vasculature are unknown. We hypothesized that chronic ...

Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer. Participation ...

Tamoxifen isn’t just used to shrink tumors or manage cancer growth—it plays a central role in preventing recurrence and ...

For the first time, chemists have discovered a unique way to control and modify a type of compound widely used in medicines, ...

A daily medication relied on by more than half a million women is under urgent recall after a critical test failure raised ...

The UK's medicines regulator has issued an urgent recall for a batch of Tamoxifen tablets after the pills failed crucial ...

Tamoxifen, an agent kept on life support for the first 20 years of its existence (1962–1982), evolved into the first targeted medicine for breast cancer.

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Purpose To update the 2002 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. Methods A literature search identified relevant ...